The Clinical Trial Vanguard·4 min read·hard
GLP-1 Agonists Are Quietly Reducing Addiction Hospitalizations, But Only While Patients Take Them
L
Leonardo Vando, M.D.
✦AI Summary
A recent study indicates that GLP-1 receptor agonists, commonly used for weight loss, are associated with reduced hospitalizations for substance use disorders. However, the protective effect for general substance use disorders disappears once the medication is discontinued, suggesting a complex neurological mechanism.
What should we do with a drug that appears to treat addiction without being designed to?
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in